Article Information
History
- October 7, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- 1Center for Discovery and Innovation in Parasitic Diseases, Skaggs School for Pharmacy and Pharmaceutical Sciences, University of California—San Diego, La Jolla, California, United States of America
- 2Division of Infectious Diseases, Department of Internal Medicine, Stanford University School of Medicine, Stanford, California, United States of America
- 3Janssen Research and Development, LLC, Ja Jolla, California, United States of America
- ↵*Corresponding author, E-mail: rabagyan{at}health.ucsd.edu (RA)
↵¶ These authors contributed equally to this work
Posted October 07, 2021.
High-throughput phenotypic screen identifies a new family of potent anti-amoebic compounds
